RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy
نویسندگان
چکیده
منابع مشابه
Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer.
BACKGROUND Breast cancer, the most common cancer affecting women in the USA and UK, is known to have a high frequency of osteolytic bone metastasis. Receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) are a group of important regulators for osteoclast differentiation and activation. These molecules have been implicated in bone metastasis. Since the discovery o...
متن کاملRANK/RANKL expression in prostate cancer
Bone is the most common metastatic site in patients with rostate cancer. Skeletal-related events consisting of pathological racture, spinal cord compression, and intractable pain are causes f a reduced quality of life for patients [1,2]. Denosumab (XGEVA), human monoclonal antibody against receptor activator of nuclear actor kappa B ligand (RANKL), was found to be a new therapeutic ption for bo...
متن کاملRANK, RANKL and OPG Expression in Breast Cancer - Influence on Osseous Metastasis.
In women, malignant breast tumours are among the most common malignant diseases in Europe. In advanced breast cancer, the risk of bone metastasis increases to 65-75 %. The discovery of the physiological bone metabolism parameters RANK (receptor activator of nuclear factor-κB), RANKL (receptor activator of nuclear factor-κB ligand) and OPG (osteoprotegerin) as well as their pathophysiological in...
متن کاملRANK–RANKL signalling in cancer
Oncogenic events combined with a favourable environment are the two main factors in the oncological process. The tumour microenvironment is composed of a complex, interconnected network of protagonists, including soluble factors such as cytokines, extracellular matrix components, interacting with fibroblasts, endothelial cells, immune cells and various specific cell types depending on the locat...
متن کاملBreast cancer during pregnancy.
The care of a pregnant breast cancer patient is a challenging clinical situation that historically has placed the welfare of the mother in conflict with that of the fetus. For the woman in this situation, the emotions usually associated with pregnancy can be overshadowed by the emotions aroused by a diagnosis of breast cancer and its subsequent treatment. The majority of published information o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Breast Cancer Research
سال: 2015
ISSN: 1465-542X
DOI: 10.1186/s13058-015-0538-7